Biotechnology company
Issues related to COVID-19 research and development, vaccine distribution and manufacturing; Issues related to Oncology; Next Generation COVID-19 vaccines and boosters; Medicare Part B and HPV; Issues related to BARDA/ASPR and manufacturing of COVID-19 vaccines and boosters; Prescription Drug User Fee Act (PDUFA); Medical Device User Fees Amendment (MDUFA IV); ARPA-H Act, H.R 5585; Accelerated Approval Integrity Act of 2022, H.R. 6963; Speeding Therapy Access Today (STAT) Act, H.R. 1730; Prevent Pandemic Act, S. 3799 FY 2023 appropriations - LHHS, AG/FDA, State, Foreign Ops
HCR - Health Issues BUD - Budget/Appropriations
25 - Defense, Dept of (DOD) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 39 - State, Dept of (DOS) 12 - White House Office 2 - HOUSE OF REPRESENTATIVES
INOVIO PHARMACEUTICALS, INC.
660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA, 19462, US
COOKAB HASHEMI COOKAB HASHEMI